HC Bioscience, Inc. Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

HC Bioscience, Inc. is a small biotechnology company based in Cambridge, Massachusetts, focused on developing tRNA-based therapeutics that address protein dysfunction caused by genetic diseases. The company centers its work on a family of therapeutic tRNAs known as PTCX tRNA, with the aim of enabling precision protein editing and potentially treating multiple conditions with a single therapy, regardless of the specific gene or mutation location. This positioning places HC Bioscience within the biotechnology research sector as it pursues translational work toward clinically relevant protein-level interventions.

Its focus is on partnerships and collaboration within the genetic disease therapeutics space, including early preclinical data presented for Duchenne muscular dystrophy and severe hemophilia A. In 2024, the company announced leadership appointments, adding a Chief Business Officer in September and a Chief Financial Officer in August. The organization has publicly shared preclinical findings from industry events, such as CureDuchenne FUTURES National Conference and the World Congress of the World Federation of Hemophilia.

Get verified HC Bioscience, Inc. emails free

Company overview Employee directory